We achieve 100% precision in all Solid-Phase Peptide Synthesis, Peptide therapeutics, Research Peptides, Peptide Nucleic Acid, Oligonucleotide Synthesis, and Peptoids cleavage.

Current Research: Among retatrutide predecessors are Tirzepatide (Mounjaro), a GLP-1/GIP dual receptor co-agonist; Liraglutide (Victoza, Saxenda), Exenatide (Byetta), Semaglutide (Ozempic, Rybelsus, Wegovy), Lixisenatide (Adlyxin), and Dulaglutide ( Trulicity), which are GLP-1 receptor agonists. Survodutide is a Glucagon/GLP-1 dual receptor co-agonist. 

For research only, you must be 21 or older. Contact us for the payment link..